Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) EBIT Margin (2017 - 2020)

Historic EBIT Margin for Cogent Biosciences (COGT) over the last 4 years, with Q3 2020 value amounting to 18333.01%.

  • Cogent Biosciences' EBIT Margin fell 171530100.0% to 18333.01% in Q3 2020 from the same period last year, while for Dec 2020 it was 1044.33%, marking a year-over-year decrease of 9013100.0%. This contributed to the annual value of 10887.1% for FY2025, which is N/A changed from last year.
  • According to the latest figures from Q3 2020, Cogent Biosciences' EBIT Margin is 18333.01%, which was down 171530100.0% from 1402.08% recorded in Q2 2020.
  • Over the past 5 years, Cogent Biosciences' EBIT Margin peaked at 14.65% during Q4 2019, and registered a low of 18333.01% during Q3 2020.
  • Its 4-year average for EBIT Margin is 1640.08%, with a median of 332.18% in 2017.
  • Over the last 5 years, Cogent Biosciences' EBIT Margin had its largest YoY gain of 3005100bps in 2020, and its largest YoY loss of -171530100bps in 2020.
  • Cogent Biosciences' EBIT Margin (Quarter) stood at 324.07% in 2017, then rose by 27bps to 236.64% in 2018, then skyrocketed by 106bps to 14.65% in 2019, then tumbled by -125223bps to 18333.01% in 2020.
  • Its EBIT Margin was 18333.01% in Q3 2020, compared to 1402.08% in Q2 2020 and 87.34% in Q1 2020.